FERON LLC is Russian pharmaceutical company with integrated business cycle, which includes R&D, production and promotion of a ... ntiviral immunomodulatory medication VIFERON® (rectal suppositories, ointment and gel). The company was founded in 1996 by leading experts in immunology and pharmaceutical engineering under the leadership of professor Valentina V. Malinovskaya, Sc.D. The original formula of VIFERON® consists of the human recombinant interferon Alpha-2B and high level antioxidants potentiating the therapeutic effect of interferon. The unique product formula is patented (№№ 2024253, 120337) For over 20 years of operation the Company has gained a wealth of experience in administrating VIFERON® to treat a wide range of diseases (ARVI and influenza, herpesviral and urogenital infections, viral hepatitis B, C and D), supported by numerousGСP-conforming clinical trials conducted in leading hospitals in Russia and CIS. VIFERON® is present in Russian and 11 CIS countries (Belorussia, Moldova, Kazakhstan, Uzbekistan, Georgia, Azerbaijan, Kirgizstan, Armenia, Turkmenistan, Tajikistan, Mongolia). FERON LLC is: - The largest manufacturer of the recombinant interferon alpha-based pharmaceuticals in Russia and CIS* - TOP 5* Russian brands by sales of immune stimulating and immune modulating medications, as well as medications with direct antiviral action (according to IMS report on L03 and J05 categories sales in 2016) - One of the first in Russia to receive the statement of conformity to the requirements of international Good Manufacturing Practice standards, granted by the Ministry of Industry and Trade of the Russian Federation (№ GMP-0017- 000022/15 as of 16.03.2015). read more